Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
I just don’t get why they be so focused on trans. You would think their base would even get tired of this shit when prices are still crazy and people losing benefits, but I guess bullying 0.5% of the population helps them cope.
Fuck them. I'm not going through the process until mine expires in 10 years
His sycophants brag about how little he sleeps at night, lol. It’s cause he’s catching cat naps all day.
Who said this?Hey remember though his mental and physical status isn't important because the election is over
Who said this?
At a White House press conference Thursday announcing lower costs for weight-loss drugs, Donald Trump decided to ask for part of a company.
Trump was sitting at his desk in the Oval Office surrounded by health officials from his administration, as well as executives from pharmaceutical companies Novo Nordisk and Eli Lilly. When a reporter asked the president about Novo Nordisk’s acquisition of an obesity biotech company, Trump quipped to CEO Maziar Mike Doustdar, “Maybe you should give us a piece of the company like I’ve been asking for, give the United States a nice big chunk of the company.”
Doustdar chuckled but ignored the president’s suggestion and went on to explain the acquisition. It’s unclear how serious Trump is about asking for a piece of the pharmaceutical giant, but his government has already taken stakes in several American companies, including U.S. Steel, Intel, Trilogy Metals, Lithium Americas, and MP Materials.
If not for a patient on Eli Lilly’s GLP-1 medication physically collapsing during the press conference, Trump’s open desire for a piece of Novo Nordisk might have been the headline from the meeting, and not the supposed goal of lowering drug prices. The president has repeatedly claimed that he would lower drug prices (often by mathematically impossible amounts) and announced that the government would launch a website to sell prescription drugs directly to the American people.
If Trump decides to go ahead and pursue a piece of Novo Nordisk, he would be under more public pressure to successfully lower the cost of prescriptions. However, his ill-advised tariff policies feeding into his poor handling of the economy might undermine that goal.